Emergent BioSolutions Inc
NYSE:EBS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emergent BioSolutions Inc
NYSE:EBS
|
US |
|
S
|
Serco Group PLC
OTC:SECCF
|
UK |
|
P
|
Precision BioSciences Inc
XBER:PBS
|
US |
|
I
|
International Game Technology PLC
F:7IG
|
UK |
|
Fagerhult AB
STO:FAG
|
SE |
|
Hind Aluminium Industries Ltd
BSE:531979
|
IN |
|
I
|
Index Living Mall PCL
SET:ILM
|
TH |
|
A
|
Adaptive Biotechnologies Corp
F:1HM
|
US |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
DUS:SLL
|
AT |
|
G
|
Goldman Sachs BDC Inc
F:GSB
|
US |
|
S
|
Stora Enso Oyj
OMXH:STERV
|
FI |
|
Salim Ivomas Pratama Tbk PT
IDX:SIMP
|
ID |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
E
|
EZCORP Inc
F:EZ2A
|
US |
|
C
|
Consumer Portfolio Services Inc
F:FC8
|
US |
|
I
|
IDEX Corp
F:ID7
|
US |
|
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
XBER:RIG2
|
HU |
|
B
|
Bear Creek Mining Corp
F:OU6
|
CA |
|
Shanghai Electric Group Co Ltd
OTC:SIELY
|
CN |
|
A
|
Atlantic Sapphire ASA
XMUN:4AS
|
NO |
|
A
|
American States Water Co
SWB:FDK
|
US |
|
Perusahaan Gas Negara Tbk PT
OTC:PPAAF
|
ID |
|
L
|
Link Mobility Group Holding ASA
OSE:LINK
|
NO |
|
BCE Inc
TSX:BCE
|
CA |
Wall St Price Targets
EBS Price Targets Summary
Emergent BioSolutions Inc
According to Wall Street analysts, the average 1-year price target for EBS is 12.24 USD with a low forecast of 12.12 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EBS's stock price target?
Price Target
12.24
USD
According to Wall Street analysts, the average 1-year price target for EBS is 12.24 USD with a low forecast of 12.12 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for Emergent BioSolutions Inc?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 1 year is -9%.
What is the Operating Income forecast for Emergent BioSolutions Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 17%.
What is the Net Income forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 1 year is 4%.
